A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus ...
The FDA has approved GRAFAPEXâ„¢ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...
The Food and Drug Administration (FDA) has approved Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft vs host disease (SR-aGvHD) in pediatric patients 2 months of age ...
Company prepares to advance to Phase 2 clinical trial in early 2025HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an ...
The Food and Drug Administration (FDA) has approved Grafapex â„¢ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...
Kennedy’s potential ascent as HHS secretary brings promise for backers of alternative-health approaches, while skeptics say ...
A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe addition to preventing graft-versus-host disease in patients undergoing stem cell transplantation for blood ...
Amneal Pharmaceuticals has received approval ... Giant Cell Astrocytoma, a brain tumor linked to patients with TSC. The company noted that there are currently limited suppliers of the treatment.
The US Food and Drug Administration (FDA) will soon decide on whether to expand the label of MSD’s Welireg (belzutifan) to ...
Autolus has picked up its first product approval, getting an FDA green light for ... or obe-cel) for the treatment of adults with relapsed or refractory B-cell precursor ALL based on the results ...